Management of Acute Otitis Externa

First‑Line Topical Therapy

The American Academy of Otolaryngology recommends topical antibiotic‑steroid combination ear drops as the first‑line treatment for uncomplicated acute otitis externa; all FDA‑approved formulations have comparable efficacy. 1
Topical antimicrobial ear drops (preferably antibiotic‑steroid combinations) should be prescribed as the primary therapy for uncomplicated disease. 1
All FDA‑approved ear drops for acute otitis externa are highly effective, with no consistent advantage of any single drug over another. 1

Treatment Duration & Continuation

A minimum of 7 days of topical therapy is advised even if symptoms improve earlier, to reduce relapse risk. 1
If symptoms persist beyond 7 days, continue the drops until resolution, but do not exceed an additional 7 days (maximum 14 days total). 1

Pain Management

Systemic analgesics are essential for relief during the first 48–72 hours while topical drops take effect. 1
Pain‑relieving (anesthetic) ear drops are not recommended because they may mask a delayed therapeutic response. 1

Aural Toilet & Ear Canal Preparation

Removal of obstructing cerumen or debris may be required to allow adequate medication penetration. 2
Irrigation of the ear canal should be avoided in patients who are diabetic or immunocompromised, as it can predispose to necrotizing otitis externa. [3][4]

High‑Risk Patient Modifications

Diabetes / Immunocompromised State

These patients have a higher risk of necrotizing otitis externa and otomycosis and may require systemic antibiotics in addition to topical therapy. [3][4]
Ear canal irrigation must be avoided. 4

Tympanic Membrane Perforation or Tympanostomy Tubes

Only ear drops that are approved for middle‑ear use (ototopically safe) should be used. 1
If the patient reports a taste of the drops, this suggests a perforation and the clinician should be notified. 1

Prior Radiotherapy

Systemic antimicrobials may be needed because tissue healing is compromised. 3

Necrotizing (Malignant) Otitis Externa

Suspect in elderly, diabetic, or immunocompromised patients with severe ear pain, granulation tissue at the bony‑cartilaginous junction, or cranial‑nerve deficits (e.g., facial palsy). [4][3]
Management requires surgical debridement and systemic antibiotics covering Pseudomonas aeruginosa and MRSA. [3][4]
Diagnosis is supported by an elevated erythrocyte sedimentation rate and imaging (CT/MRI). 3

Otomycosis (Fungal Infection)

Consider when initial topical antibiotic therapy fails; characteristic findings include pruritus and colored debris (black, gray, bluish‑green, yellow, or white). [3][4]
Topical antibiotics are contraindicated because they promote fungal overgrowth; treatment consists of canal debridement plus topical antifungal agents. [3][4]

Systemic Antibiotic Use

Oral antibiotics are generally ineffective against the primary pathogens (Pseudomonas aeruginosa and Staphylococcus aureus) and carry undesirable side effects and resistance risks; therefore, they should be avoided in uncomplicated acute otitis externa. 2

Alternative/Adjunct Topical Agents

Acetic acid (vinegar) solutions may be used for initial therapy or prevention, showing comparable effectiveness to antibiotic‑steroid drops at 1 week. 1

Patient Education & Prevention

During Treatment

Patients should avoid scratching or inserting objects (including cotton swabs) into the ear canal. 1
Protect the ear with an earplug or petroleum‑jelly‑coated cotton before showering. 1
Physicians should be consulted before swimming or other water activities. 1

Common Pitfalls to Avoid

Do not use ear candles—they cause canal obstruction, hearing loss, and tympanic membrane perforation without benefit. 1
Do not prescribe systemic antibiotics for uncomplicated disease. 2
Do not use topical antibiotics when a fungal infection is suspected. [3][4]
Do not irrigate ears in diabetic or immunocompromised patients. [3][4]

Expected Clinical Course

Symptoms should begin to improve within 48–72 hours of initiating therapy; lack of improvement warrants physician reassessment. 1

Guidelines for Diagnosis and Management of Acute Otitis Externa (AOE)

Diagnostic Approach

The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) recommends that the first step in evaluating ear discharge is to differentiate acute otitis externa from other etiologies by performing a focused otoscopic examination of the external auditory canal. 5
Diffuse inflammation of the external ear canal, with or without involvement of the pinna or tympanic membrane, confirms the diagnosis of AOE according to AAO‑HNS. 6

Assessment of High‑Risk Modifying Factors

AAO‑HNS advises checking the integrity of the tympanic membrane (e.g., perforation or presence of tympanostomy tubes) before initiating standard therapy, as these findings may alter management. 5

Pain Management

AAO‑HNS suggests assessing pain severity in patients with AOE and prescribing appropriate systemic analgesics for the first 48–72 hours while topical therapy takes effect. 5

Antibiotic Stewardship

AAO‑HNS recommends against routine oral antibiotics for uncomplicated AOE because they are generally ineffective against Pseudomonas aeruginosa and Staphylococcus aureus, increase adverse‑event risk, and promote resistance. 6
Only 20–40 % of patients with AOE should receive oral antibiotics, specifically those with disease extension beyond the ear canal or with host factors that increase risk of complications. 6

Management Modifications for Specific Clinical Situations

When a tympanic membrane perforation or tympanostomy tubes are present, AAO‑HNS recommends using only ototopically safe (non‑ototoxic) ear drops that are approved for middle‑ear use. 5

Follow‑up and Reassessment

AAO‑HNS advises reassessing patients who do not show clinical improvement within 48–72 hours to confirm the diagnosis and exclude alternative causes of otorrhea. 5
If symptoms persist after this interval, clinicians should reconsider the diagnosis or modify the treatment plan. 5

First‑Line Management of Uncomplicated Acute Otitis Externa

Primary Topical Therapy

The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) recommends topical antibiotic‑steroid combination ear drops as the first‑line treatment for uncomplicated acute otitis externa; all FDA‑approved formulations have comparable efficacy. [Strong evidence, Level A] 7
Topical antimicrobial drops achieve drug concentrations in the ear canal that are 100‑ to 1,000‑fold higher than systemic antibiotics can attain at the infection site, providing superior local activity. [Strong evidence, Level A] 8
Meta‑analyses of randomized controlled trials confirm that topical therapy is highly effective as first‑line treatment, with no meaningful differences in cure rates between drug classes (antibiotic vs antiseptic) or between quinolone and non‑quinolone preparations. [Strong evidence, Level A] 8
All FDA‑approved ototopical preparations demonstrate high efficacy, and no single drug has a consistent advantage over another. [Strong evidence, Level A] 8

Treatment Duration

Topical drops should be prescribed for a minimum of 7 days, even if symptoms improve earlier, to minimise the risk of relapse. [Strong evidence, Level A] 9
If symptoms persist after 7 days, therapy may be continued until resolution but should not exceed an additional 7 days (maximum total of 14 days). [Strong evidence, Level A] 9

Analgesia and Adjunctive Care

Systemic analgesics (e.g., acetaminophen or NSAIDs) are advised for the first 48‑72 hours while topical therapy takes effect. [Strong evidence, Level A] 9
Anesthetic ear drops are not recommended because they can mask delayed therapeutic response and are unsuitable for active ear‑canal infection. [Strong evidence, Level A] 9

Aural Toilet (Canal Cleaning)

Removal of obstructing cerumen or debris is essential to allow adequate penetration of topical medication into the ear canal. [Strong evidence, Level A] 7

Oral Antibiotics – Contraindicated in Uncomplicated Disease

Oral antibiotics should not be prescribed for uncomplicated acute otitis externa. [Strong evidence, Level A] 7, 8
Systemic antibiotics are generally ineffective against the primary pathogens (e.g., Pseudomonas aeruginosa and Staphylococcus aureus) and expose patients to unnecessary side‑effects, promote antimicrobial resistance, and fail to achieve therapeutic concentrations at the infection site. [Strong evidence, Level A] 7, 8
Randomized trials demonstrate no significant difference in cure rates between oral antibiotics and topical therapy for uncomplicated disease. [Strong evidence, Level A] 8

Microbiologic Rationale

Approximately 98 % of acute otitis externa cases in North America are bacterial in origin. [Strong evidence, Level A] 7, 10
The most common bacterial isolate is Pseudomonas aeruginosa (≈ 38 % of isolates), supporting the use of broad‑spectrum topical agents with anti‑Pseudomonas activity. [Strong evidence, Level A] 7

Expected Clinical Course and Follow‑up

Most patients experience symptomatic improvement within 48‑72 hours and have minimal residual symptoms by 7 days of appropriate topical therapy. [Strong evidence, Level A] 9
Patients who do not improve within 48‑72 hours should be reassessed to confirm the diagnosis and exclude alternative etiologies. [Strong evidence, Level A] 9

Safety Alerts and Special Situations

If a patient reports a taste of the ear drops, this may indicate tympanic membrane perforation; clinicians should verify perforation status and select only ototopically safe (non‑ototoxic) preparations approved for middle‑ear use. [Strong evidence, Level A] 9
Ear candles provide no therapeutic benefit and can cause canal obstruction, hearing loss, and tympanic membrane perforation; they should be avoided. [Strong evidence, Level A] 9

Management of Acute Otitis Externa in Adults

First‑Line Topical Therapy

The American Academy of Otolaryngology‑Head and Neck Surgery recommends a topical antibiotic‑steroid combination ear drop as the standard of care for uncomplicated acute otitis externa; all FDA‑approved formulations have comparable clinical efficacy, allowing selection based on cost, dosing frequency, and patient preference. 11
Topical antibiotic‑steroid drops achieve drug concentrations 100‑ to 1,000‑fold higher at the infection site than systemic antibiotics, providing superior local antimicrobial activity. 11
The most common causative organisms are Pseudomonas aeruginosa (≈20‑60 % of cases) and Staphylococcus aureus (≈10‑70 %), frequently in polymicrobial infections. 11
Oral antibiotics are not recommended for uncomplicated disease because they are generally ineffective against the primary pathogens, expose patients to unnecessary adverse effects, and promote antimicrobial resistance; nevertheless, 20‑40 % of patients receive them inappropriately. 11

Duration of Therapy

A minimum of 7 days of topical therapy is advised even if symptoms resolve earlier; treatment may be extended up to 14 days if symptoms persist, but should not exceed this total duration. 12

Dosing and Administration Technique

Drops should be instilled with the patient lying down, affected ear up, filling the canal completely. 12
The patient must remain in this position for 3‑5 minutes to allow adequate penetration; gentle tragal pumping or pinna movement helps eliminate trapped air. 12
When feasible, an assistant should administer the drops—self‑administration is correct in only ~40 % of patients during the first three days, whereas assisted administration markedly improves adherence. 12

Essential Adjunctive Measures

Aural Toilet (Canal Cleaning)

Prior to drop administration, obstructing cerumen or debris should be removed to ensure adequate drug delivery. 12
Cleaning methods include gentle lavage with body‑temperature saline, suction, or dry mopping with a cotton‑tipped applicator under direct visualization. 12

Wick Placement

In cases of severe canal edema or obstruction, an ear wick should be placed to facilitate drug diffusion; the wick typically dislodges spontaneously within 1‑3 days as edema resolves, indicating treatment response. [12][13]

Pain Management

Systemic analgesics (acetaminophen or NSAIDs) should be prescribed for the first 48‑72 hours while topical therapy takes effect. 14
Anesthetic ear drops are contraindicated in active infection because they can mask delayed therapeutic response. 14

Special Populations

Tympanic Membrane Perforation or Tympanostomy Tubes

Use non‑ototoxic, middle‑ear‑approved topical preparations (e.g., fluoroquinolone drops without aminoglycosides). 13
If the patient reports a taste of the drops, suspect a perforated membrane and verify integrity. 14
Aminoglycoside‑containing drops (neomycin, gentamicin) should be avoided due to ototoxicity risk with middle‑ear exposure. 13

Follow‑Up and Expected Clinical Course

Symptom improvement is typically observed within 48‑72 hours, and most patients are minimally symptomatic or asymptomatic by day 7. 14

Critical Pitfalls to Avoid

Ear candles provide no benefit and can cause canal obstruction, hearing loss, and tympanic membrane perforation. 14
Patients should be instructed not to insert objects (including cotton swabs) into the ear canal. 14
Protect the ear with an earplug or petroleum‑jelly‑coated cotton before showering and obtain guidance before resuming swimming. 14

Acute Otitis Externa – Evidence‑Based Topical Management

Primary Treatment

Topical antibiotic‑steroid combination ear drops are recommended as the first‑line therapy for patients ≥ 2 years old with diffuse acute otitis externa. This recommendation follows the American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) guideline. 15
Topical agents achieve drug concentrations 100‑ to 1,000‑fold higher at the infection site than systemic antibiotics, delivering superior activity against the principal pathogens Pseudomonas aeruginosa (≈ 20‑60 % of cases) and Staphylococcus aureus (≈ 10‑70 % of cases). 16

Treatment Duration & Administration

Continue topical drops for a minimum of 7 days, even if symptoms improve earlier, to minimise relapse; if symptoms persist, extend therapy up to a total of 14 days. 17
After instilling drops, the patient should remain with the treated ear up for 3‑5 minutes to allow adequate penetration; gentle tragal pumping can help eliminate trapped air. 17
Systemic analgesics (acetaminophen or NSAIDs) are advised for the first 48‑72 hours while the topical medication takes effect. 17
Anesthetic ear drops are contraindicated because they may mask delayed therapeutic response during active infection. 17

Adjunctive Measures

Prior to initiating topical therapy, remove obstructing cerumen or debris to ensure adequate drug delivery. This step is endorsed by the AAO‑HNS. 18

Patient Education & Activity Restrictions

Patients should avoid inserting objects (including cotton swabs) into the ear canal during treatment. 17
Before showering or hair washing, the ear canal opening should be protected with an earplug or petroleum‑jelly‑coated cotton to limit water entry. 17
Physicians should be consulted before the patient resumes swimming or other water‑related activities during and shortly after infection. 17

Expected Clinical Course

Clinical improvement is typically observed within 48‑72 hours of starting appropriate topical therapy. 17
If no improvement occurs within 48‑72 hours, reassessment is recommended to confirm the diagnosis and exclude alternative causes of otorrhea. 17

Selection of Topical Therapy for Acute Otitis Externa

Therapeutic Selection Criteria

Choose a topical antibiotic‑steroid ear drop based on cost, dosing frequency, status of the tympanic membrane, and patient preference to ensure optimal adherence and safety. (American Academy of Otolaryngology–Head and Neck Surgery) 19

Management of Treatment Failure

If symptoms have not improved within 48–72 hours, systematically reassess for:

Evidence‑Based Management of Acute External Otitis

First‑Line Topical Therapy

The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) recommends a topical antibiotic‑steroid combination ear drop as the first‑line treatment for uncomplicated acute external otitis; all FDA‑approved formulations have comparable efficacy, so choice should be based on cost, dosing frequency, tympanic membrane integrity, and patient preference. 21
For patients ≥ 2 years old with diffuse disease, topical antibiotic‑steroid drops are the standard of care, delivering drug concentrations 100‑ to 1,000‑fold higher at the infection site than oral antibiotics can achieve. 21

Comparative Efficacy of Topical Preparations

AAO‑HNS notes that all FDA‑approved ototopical agents (quinolone vs. non‑quinolone, antibiotic vs. antiseptic) show similar clinical cure rates; no single agent has demonstrated consistent superiority. 22

Microbiology

The predominant pathogens in acute external otitis are Pseudomonas aeruginosa (≈ 20‑60 % of cases) and Staphylococcus aureus (≈ 10‑70 %); overall, about 98 % of cases are bacterial in origin. 23

Adjunctive Analgesia

Systemic analgesics (acetaminophen or NSAIDs) should be prescribed for the first 48‑72 hours while the topical agent takes effect, as pain is usually most severe during this period. 22

Oral Antibiotics – When to Avoid and When to Use

Oral antibiotics are not recommended for uncomplicated acute external otitis because they are generally ineffective against Pseudomonas and Staphylococcus species, expose patients to unnecessary adverse effects, and promote antimicrobial resistance. 21
Systemic antibiotics should be reserved for:

Special Consideration: Tympanic Membrane Integrity

If a patient reports a taste of the ear drops, clinicians should suspect a tympanic membrane perforation and promptly verify membrane integrity. 22

Expected Clinical Course & Follow‑Up

With appropriate topical therapy, most patients show symptomatic improvement within 48‑72 hours and have minimal or no symptoms by day 7. 22

Strength of evidence: The cited AAO‑HNS statements are based on systematic reviews and clinical studies published in 2014; specific grading (e.g., Level I, II) was not provided in the source material.

Management of Fungal Otitis Externa – Evidence‑Based Recommendations

Risk Factors and Epidemiology

Recent or current use of topical antibiotics predisposes patients to fungal otitis externa – patients who have recently completed or are presently using topical antibiotics are more likely to develop otomycosis. [American Academy of Otolaryngology‑Head and Neck Surgery] [24]
Fungal involvement is uncommon in primary acute otitis externa but becomes more frequent after treatment with topical or systemic antibiotics – the incidence of otomycosis rises following antibiotic therapy for otitis externa. [American Academy of Otolaryngology‑Head and Neck Surgery] [24]

Aural Debridement Techniques

Gentle suction under microscopic visualization is recommended for thorough removal of fungal debris – using microscopic guidance ensures precise and safe debridement. [American Academy of Otolaryngology‑Head and Neck Surgery] [25, 26]
Dry mopping with cotton‑tipped applicators should be employed as part of the debridement process – this technique helps eliminate residual fungal material without introducing moisture. [American Academy of Otolaryngology‑Head and Neck Surgery] [25, 26]

Precautions in High‑Risk Populations (Diabetic or Immunocompromised Patients)

Ear canal irrigation must be avoided – irrigation can predispose these patients to necrotizing otitis externa and should not be performed. [American Academy of Otolaryngology‑Head and Neck Surgery] [25, 26, 27]
Atraumatic cleaning with aural suctioning under microscopic guidance is required – careful suctioning under magnification is essential to safely manage the ear canal in high‑risk individuals. [American Academy of Otolaryngology‑Head and Neck Surgery] [25, 26, 27]

Oral Antibiotic Use in Acute Otitis Externa: Guideline Recommendations

General Recommendations

Oral antibiotics should not be prescribed for uncomplicated acute otitis externa; they are reserved only for cases where the infection extends beyond the ear canal, for patients who are immunocompromised or diabetic and therefore at risk for necrotizing otitis externa, or when topical therapy cannot adequately reach the infection site. American Academy of Otolaryngology‑Head and Neck Surgery guideline. [28][29]

High‑Risk Populations Requiring Systemic Therapy

Patients with diabetes, HIV infection, or other immunocompromising conditions are at high risk for necrotizing (malignant) otitis externa and should receive systemic antibiotics in addition to topical therapy, not as monotherapy. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28
In these high‑risk patients, ear‑canal irrigation must be avoided because it predisposes to necrotizing otitis externa; atraumatic cleaning with aural suction under microscopic guidance is recommended instead. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28

Necrotizing Otitis Externa

Necrotizing otitis externa should be suspected in elderly, diabetic, or immunocompromised individuals who present with severe ear pain, granulation tissue at the bony‑cartilaginous junction of the ear canal, or cranial‑nerve deficits (particularly facial nerve palsy). American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28
Management requires both surgical debridement and systemic antibiotics that cover Pseudomonas aeruginosa and methicillin‑resistant Staphylococcus aureus (MRSA). American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28
Diagnostic work‑up is supported by an elevated erythrocyte sedimentation rate and abnormal findings on CT or MRI imaging. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28

Systemic Therapy Indications

When systemic antibiotics are indicated, the chosen regimen must provide empiric coverage for Pseudomonas aeruginosa and Staphylococcus aureus, including MRSA in cases of necrotizing disease. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28

Critical Pitfalls to Avoid

Prescribing oral antibiotics for uncomplicated acute otitis externa increases adverse events, promotes antimicrobial resistance, and offers no clinical benefit over topical therapy alone. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 29
Ear‑canal irrigation in diabetic or immunocompromised patients should be avoided because it can precipitate necrotizing otitis externa. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 28

Reassessment Protocol

If a patient does not improve after 48–72 hours of initial topical therapy, reassessment is required to confirm the diagnosis and to exclude necrotizing otitis externa, fungal superinfection, allergic contact dermatitis, or alternative pathologies such as cholesteatoma, foreign body, or middle‑ear disease. American Academy of Otolaryngology‑Head and Neck Surgery guideline. 29

Topical Antibiotic‑Steroid Therapy for Uncomplicated Acute Otitis Externa

Standard of Care

The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) recommends topical antibiotic‑steroid combination ear drops as the standard treatment for uncomplicated acute otitis externa, with meta‑analyses showing 65 %–90 % clinical resolution within 7–10 days. High‑quality evidence (multiple randomized controlled trials) supports this recommendation. 30
All FDA‑approved topical antibiotic‑steroid formulations have equivalent clinical efficacy; selection should be based on cost, dosing frequency, and patient preference. [30][31]

Comparative Efficacy of Formulations

No clinically meaningful differences exist between antibiotic vs antiseptic agents, quinolone vs non‑quinolone preparations, or monotherapy vs combination (antibiotic‑steroid) therapy. Evidence derives from high‑quality RCTs and meta‑analyses. [30][31]
The AAO‑HNS guideline found no consistent advantage of antibiotic‑steroid combinations over antibiotics alone. 30

Administration Technique

Only ≈40 % of patients correctly self‑administer drops during the first three days; having an assistant apply the drops significantly improves adherence and outcomes. Moderate‑quality evidence. 32
Recommended step‑by‑step technique (supported by AAO‑HNS):

Optimizing Drug Delivery

Debridement of cerumen or debris before initiating therapy is essential; methods include gentle body‑temperature saline lavage, suction under otoscopic/microscopic visualization, or dry mopping with cotton‑tipped applicators. 32
In diabetic or immunocompromised patients, avoid ear canal irrigation because it predisposes to necrotizing otitis externa; use only atraumatic suction. 32
When severe canal edema impedes drop penetration, place an ear wick; the wick typically dislodges spontaneously within 1–3 days, indicating a positive treatment response. 32

Adjunctive Symptom Management

Prescribe systemic analgesics (acetaminophen or NSAIDs) for the first 48–72 hours while topical therapy takes effect. This recommendation is based on AAO‑HNS guidance. 31

Oral Antibiotics – When (Not) to Use

Do not prescribe oral antibiotics for uncomplicated acute otitis externa; this is a strong recommendation due to lack of benefit, unnecessary adverse effects, and promotion of antimicrobial resistance. 31
Oral antibiotics are reserved for:

Special Populations & Modifications

For patients with tympanic membrane perforation or tympanostomy tubes, use non‑ototoxic, middle‑ear‑approved topical preparations (e.g., fluoroquinolone drops) and avoid aminoglycoside‑containing drops. 31

Patient Education & Prevention

Instruct patients to keep the ear dry throughout treatment; avoid water entry. 32
Advise use of petroleum‑jelly‑coated cotton or earplugs before showering.
Prohibit insertion of objects (including cotton swabs) into the ear canal. 32

Comparative Effectiveness of Alternative Agents

The AAO‑HNS meta‑analysis indicates no consistent advantage of antibiotic‑steroid combinations over antibiotics alone. 30
A high‑quality Cochrane trial found acetic acid solutions to be significantly less effective than antibiotic‑steroid drops at 2–3 weeks (odds ratios 0.29 and 0.25), with symptoms persisting ≈2 days longer. 30

Ciprodex Use in Acute Otitis Externa – Evidence‑Based Recommendations

Pre‑Treatment Preparation

Debridement is required before starting Ciprodex; obstructing cerumen or debris should be removed to ensure adequate drug delivery (American Academy of Otolaryngology‑Head and Neck Surgery, 2014) 33
Ciprodex may be used safely when the tympanic membrane is perforated or when tympanostomy tubes are present, because it is FDA‑approved for middle‑ear use and is non‑ototoxic (AAO‑HNS, 2014) [33][34]
If severe canal edema prevents drop entry, placement of a wick is recommended; the wick typically dislodges spontaneously within 1–3 days as edema resolves (AAO‑HNS, 2014) [33][34]

Assessment of Treatment Failure

Lack of improvement within 48–72 hours should prompt evaluation for alternative diagnoses such as necrotizing otitis externa, especially in diabetic or immunocompromised patients (AAO‑HNS, 2014) 33

Adjunctive Symptom Management

Systemic analgesics (acetaminophen or NSAIDs) should be prescribed for the first 48–72 hours while topical therapy takes effect (AAO‑HNS, 2014) 33

Antibiotic Stewardship

Oral antibiotics are not indicated for uncomplicated acute otitis externa; they are ineffective against the primary pathogens (Pseudomonas aeruginosa and Staphylococcus aureus) and promote antimicrobial resistance (AAO‑HNS, 2014) 33